glp-1 and glp-2 Glucagon Like Peptide 2 Receptor - an overview Therapeutic Potential of GLP-2 Analogs

Larger randomized placebo-controlled trials including a variety of patient populations (ie, those with metabolic syndrome versus those without) are needed to confirm efficacy of GLP-1RAs according to patient type

Diabetes, depression, and quality of life: a population study

AD, Alzheimers disease

Then we used Tunel fluorescence staining to detect the apoptosis signal in islet cells and immunofluorescence staining for the value-added related antigen Ki67 (Figures 2E, F)

The logic behind alternating goes like this: if semaglutide only targets GLP-1 receptors and the body has adapted to that stimulation, switching to tirzepatide introduces GIP receptor activation as a new variable